Loading…
Chinese maker of medical dressings, cotton products and consumer health items, also known for its Purcotton brand.
Chinese maker of medical dressings, cotton products and consumer health items, also known for its Purcotton brand.
Makes medical dressings and supplies as a contract manufacturer for overseas healthcare buyers, and separately sells its own Purcotton cotton products to consumers in China online and in stores.
In one line: A Chinese medical-supplies and cotton-consumer-products maker.
Moat: narrow (brand, regulatory licence). Medical-device manufacturing licences plus the recognized Purcotton consumer brand.
Headquarters: Shenzhen, China · Employees: 15,855
Size Winner Medical (300888.SZ) is a China Consumer Staples company (Household/Personal Care) with a market value of $2.69B, the 962nd largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥30.74 on 6 Nov 2026.
Performance Over six months the shares fell 1.9%, against -5.7% for the median peer and -16.4% for the China market (cap-weighted) — 10th highest of 21 in its peer set.
Growth Revenue grew 4.1% over the last twelve months (peer median +3.0%); the operating margin is 10.6% (peer median 10.1%).
Valuation It trades at 20.9× forward earnings against a peer median of 19.2× (10th most expensive of 21).
Price implies For today's price to make sense, revenue must grow about -4% a year for seven years (Req g). Recent delivered growth is -3%, so the hurdle is -2 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 5.5 points above its cost of capital (5.8% WACC).
Next results Next results expected around 28 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥11.2B | CN¥10.9B | CN¥8.92B | CN¥8.14B | CN¥11.3B |
| Revenue growth | — | +22% | +10% | -28% | — |
| Gross profit | CN¥5.53B | CN¥4.70B | CN¥3.74B | CN¥3.55B | CN¥4.90B |
| EBITDA | n/a | CN¥1.87B | CN¥1.41B | CN¥1.25B | CN¥2.27B |
| Net income | CN¥777M | CN¥768M | CN¥695M | CN¥580M | CN¥1.65B |
| Free cash flow | CN¥905M | CN¥1.13B | CN¥558M | CN¥545M | CN¥1.94B |
| Capital expenditure | CN¥761M | CN¥648M | CN¥901M | CN¥753M | CN¥1.20B |
| Total debt | CN¥3.52B | CN¥3.29B | CN¥3.35B | CN¥2.49B | CN¥2.86B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Winner Medical 300888.SZ | $2.69B | -2% | +4% | 11% | 20.9× | -4.3% |
| Jiangsu Yuyue Medical Equipment & Supply 002223.SZ | $4.26B | -1% | -1% | 13% | 20.4× | 5.1% |
| Kimberly-Clark KMB | $66.5B | +12% | -12% | 14% | 15.3× | 4.1% |
| Zhende Medical 603301.SS | $3.33B | -8% | +8% | 7% | 43.5× | 23.2% |
| Hengan Int'l 1044.HK | $3.28B | -16% | +2% | 11% | 9.1× | -8.8% |
| ConvaTec CTEC.L | $6.44B | +22% | +2% | 16% | 16.7× | 15.6% |
| Essity ESSITY-A.ST | $19.9B | +17% | -2% | 12% | 15.4× | -3.3% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 300888.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +3.0% | +1.7% | 10th highest of 21 |
| 6-month return | -1.9% | -5.7% | 10th highest of 21 |
| Distance from 52-week high | -29.3% | -24.1% | 10th lowest of 21 |
| Revenue growth (TTM) | +4.1% | +3.0% | 9th highest of 21 |
| Operating margin | 10.6% | 10.1% | 10th highest of 21 |
| Forward P/E | 20.9× | 19.2× | 10th most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | -4.3% | 4.5% | 4th least demanding of 18 |
| Growth delivered (Del g) | -2.6% | +7.4% | 2nd lowest of 18 |
| Hurdle (Req g minus delivered) | -1.7 pp | -3.7 pp | 8th most demanding of 18 |
| ROIC minus cost of capital | +5.5 pp | +4.7 pp | 10th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Winner Medical 300888.SZ | China | $2.69B | -2% | +4% | 11% | 20.9× | -4.3% | -2.6% |
| Giant Biogene 2367.HK | Hong Kong | $2.76B | -34% | -10% | 32% | 9.7× | -8.0% | +34.9% |
| Gillette India GILLETTE.NS | India | $2.56B | -7% | +8% | 28% | 33.0× | 16.0% | +13.0% |
| LG H&h 051900.KS | South Korea | $2.56B | -8% | -3% | 3% | 18.5× | -0.1% | -4.1% |
| Proya Cosmetics 603605.SS | China | $2.97B | -19% | +2% | 13% | 11.1× | -4.8% | +23.1% |
| Procter & Gamble Hygiene & Health Care PGHH.NS | India | $2.40B | -29% | -2% | 24% | 27.3× | 15.4% | +7.4% |
| Lion 4912.T | Japan | $3.19B | +21% | +6% | 8% | 19.9× | -2.4% | +3.5% |
| Softcare 2698.HK | Hong Kong | $2.20B | -5% | +25% | 25% | 14.4× | 8.7% | +20.9% |
| Hengan Int'l 1044.HK | Hong Kong | $3.28B | -16% | +2% | 11% | 9.1× | -8.8% | -0.1% |
| Kobayashi Pharmaceutical 4967.T | Japan | $3.29B | +20% | +4% | 6% | 50.2× | 17.6% | +1.9% |
| KOSE 4922.T | Japan | $2.16B | +7% | +3% | 4% | 27.2× | n/a | n/a |
| Cosmax 192820.KS | South Korea | $2.13B | +21% | +16% | 8% | 16.6× | n/a | n/a |
| Coty COTY | United States | $3.57B | +64% | -1% | 5% | 13.3× | 11.3% | +4.6% |
| Interparfums ITP.PA | France | $3.65B | +72% | -4% | 18% | 27.5× | 15.9% | +19.6% |
| Pola Orbis 4927.T | Japan | $1.96B | +8% | +1% | 10% | 28.8× | -3.1% | -0.7% |
| Kolmar Korea 161890.KS | South Korea | $1.89B | +23% | +13% | 10% | 13.0× | -0.9% | +15.5% |
| Blue Moon 6993.HK | Hong Kong | $1.88B | -15% | -2% | -2% | 93.6× | n/a | n/a |
| Yunnan Botanee Bio-Technology 300957.SZ | China | $1.84B | -28% | +7% | 9% | 21.2× | 4.5% | +15.3% |
| Rohto Pharmaceutical 4527.T | Japan | $3.97B | +17% | +10% | 12% | 16.7× | -2.1% | +13.7% |
| Emami EMAMILTD.NS | India | $1.80B | -15% | +3% | 20% | 21.4× | 21.7% | +5.6% |
| Shanghai Jahwa United 600315.SS | China | $1.74B | -13% | +9% | 2% | 18.1× | 17.1% | -2.1% |